news
MRC forges two new deals with industry to speed drug discovery
The Medical Research Council has formed partnerships with UCB and AstraZeneca, the deals will help speed translation of discovery research into potential therapies...
List view / Grid view
UCB Pharma
news
UCB and Baylor enter neurodegenerative disease research alliance
9 February 2016 | By Victoria White
The research will be led at Baylor by Professor Huda Zoghbi who is world renowned in the field of neurodegenerative disease research...
article
The impact of phenotypic and functional screening in CNS drug discovery
Wolfgang Fecke and Christine Williams from UCB discuss the industry’s approach to drug discovery with costs escalating and output failing to achieve the corresponding increases in revenue...
news
MRC and UCB collaborate to offer access to UCB’s novel antibody discovery platform
30 March 2015 | By Victoria White
The MRC and UCB are to launch a collaboration that will provide scientists with access to cutting-edge technologies to discover new monoclonal antibodies...
article
Antibody Discovery Technologies: the partnership between academia and biopharma in the therapeutic monoclonal antibody success story
The use of monoclonal antibodies and antibody-based molecules as therapeutics to treat patients suffering with severe disease has become a major success story. Due to the exquisite specificity with which they interact with their antigen and the fact that their large binding surface can intervene at sites and targets not…
news
Sanofi and UCB partner for breakthrough innovation in immune-mediated diseases
12 March 2014 | By Sanofi
Sanofi and UCB announce they have entered into a scientific and strategic collaboration for the discovery and development of innovative anti-inflammatory small molecules...